Viridian Therapeutics, Inc.\DE (VRDN) Amortizatization of Intangibles (2016 - 2026)

Viridian Therapeutics, Inc.\DE's (VRDN) quarterly Amortizatization of Intangibles came in at $1.9 million in Q1 2026, down 19.96% year-on-year from $2.3 million in Q1 2025, and up 5.93% quarter-over-quarter from $1.8 million in Q4 2025.

Viridian Therapeutics, Inc.\DE (VRDN) Amortizatization of Intangibles (2016 - 2026) Analysis & Trends

Viridian Therapeutics, Inc.\DE's Amortizatization of Intangibles history runs 11 years deep, the most recent figure standing at $1.9 million for Q1 2026.

  • On a quarterly basis, Amortizatization of Intangibles fell 19.96% year-over-year to $1.9 million in Q1 2026; TTM through Mar 2026 was $6.3 million, a 52.71% decrease from a year earlier, with the FY2025 full-year figure at $6.8 million, down 56.83% from the prior year.
  • Amortizatization of Intangibles climbed to $1.9 million in Q1 2026 per VRDN's latest filing, from $1.8 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $4.7 million in Q1 2024 and bottomed at -$274000.0 in Q1 2022.
  • The 5-year median for Amortizatization of Intangibles is $2.3 million (2025), against an average of $2.1 million.
  • Across the five-year window, Amortizatization of Intangibles surged 1415.54% in 2023 and slumped 66.45% in 2025, its largest moves.
  • Year by year, Amortizatization of Intangibles stood at $937000.0 in 2022, then jumped by 227.32% to $3.1 million in 2023, then grew by 4.56% to $3.2 million in 2024, then tumbled by 45.34% to $1.8 million in 2025, then advanced by 5.93% to $1.9 million in 2026.
  • Per Business Quant, the three latest VRDN Amortizatization of Intangibles figures stand at $1.9 million (Q1 2026), $1.8 million (Q4 2025), and $1.1 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Viridian Therapeutics, Inc.\DE 655.26 Mn 655.26 Mn - 1.86 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.86 Mn
Mar 31, 2026 1.86 Mn
Dec 31, 2025 1.75 Mn
Dec 31, 2025 1.75 Mn
Sep 30, 2025 1.13 Mn
Sep 30, 2025 1.13 Mn
Jun 30, 2025 1.55 Mn
Jun 30, 2025 1.55 Mn
Mar 31, 2025 2.32 Mn
Mar 31, 2025 2.32 Mn
Dec 31, 2024 3.21 Mn
Dec 31, 2024 3.21 Mn
Sep 30, 2024 3.38 Mn
Sep 30, 2024 3.38 Mn
Jun 30, 2024 4.41 Mn
Jun 30, 2024 4.41 Mn
Mar 31, 2024 4.66 Mn
Mar 31, 2024 4.66 Mn
Dec 31, 2023 3.07 Mn
Dec 31, 2023 3.07 Mn